1. European Medicines Agency/CHMP/128918/2005: Press Release: European Medicines Agency finalises review of antidepressants in children and adolescents. [Accessed 18 February 2010], [
http://www.ema.europa.eu/pdfs/human/press/pr/12891805en.pdf
]
2. Meeting highlights from the Committee for Medicinal Products for Human Use (EMEA/431407/2007). [Accessed 18 February 2010], [
http://www.emea.europa.eu/pdfs/human/press/pr/43140707en.pdf
]
3. European Medicines Agency makes recommendations for safer use of Ritalin and other methylphenidate-containing medicines in the EU (EMEA/22315/2009). [Accessed 18 February 2010], [
http://www.ema.europa.eu/pdfs/human/referral/methylphenidate/2231509en.pdf
]
4. Cheung A, Sacks D, Dewa CS, Pong J, Levitt A: Paediatric prescribing practices and the FDA Black-box warning on antidepressants. J Dev Behav Pediatr. 2008, 29: 213-15. 10.1097/DBP.0b013e31817bd7c9.
5. Aagaard L, Christensen AC, Hansen EH: Information about adverse drug reactions reported in children: a qualitative review of empirical studies. Br J Clin Pharmacol. 2010,